Medicine passport

TYSABRI 20 mg

The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.

Active substance
Natalizumab
Strength
20 mg
Form
concentrado para solución para perfusión
ATC code
L04AG03
Registered in
Spain · Biogen Netherlands B.V.
Prescription
Prescription only
Nº Registro
06346001

Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30

Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.

Listed in other countries

France 2 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
TYRUKO20 mg · solution à diluer pour perfusionPrescription onlySANDOZ (AUTRICHE)60779570
TYSABRI20 mg · solution à diluer pour perfusionPrescription onlyBIOGEN NETHERLANDS (PAYS-BAS)68722564

Source: Base de données publique des médicaments (ANSM / Ministère de la Santé) · 2026-09-30 · Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte.

Same active substance, but no match for this strength and form

Countries covered: United States, Bulgaria, European Union, Spain, France, Netherlands, Canada, Switzerland. A country missing from the list may still sell this medicine: Mediclarum reads only these registers.

Register data as of 2026-09-30. Mediclarum stores nothing about you for this page. https://www.mediclarum.com/es/en/medicines/tysabri-20-mg-concentrado-para-solucion-para-perfusion